SEEQ™ Performance Study

Medtronic

Status: Completed

Conditions: Arrhythmia Type Unknown

Study type: Observational

Funder types: Industry

Identifiers

NCT02484898

SEEQ™ Performance Study

Details and patient eligibility

About

The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).

Enrollment: 200 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient is indicated for a SEEQ™ MCT/ECM System for approved indications
• Patient is 18 years of age or older
• Patient is willing and able to provide consent and authorize the use and disclosure of health information
• Patient is willing and able to comply with the protocol

Exclusion criteria

• Patient has known allergy and/or hypersensitivity to adhesives or hydrogel.
• Patient has suspected potential life-threatening arrhythmias, or requires in-subject/in-hospital monitoring.
• Patient will undergo a medical procedure that would preclude full participate during the prescribed duration of the SEEQ™
• Patient has an implanted cardiac device, (e.g., pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy)

Trial design

200 participants in 1 patient group

SEEQ™ MCT/ECM System

Description:

SEEQ™ MCT/ECM monitoring for the detection of non-lethal cardiac arrhythmias.